ORLANDO, FL--(Marketwire - February 14, 2008) - Cardiovascular Sciences, Inc. (PINKSHEETS: CVSC) announced that the recent funding event, in association with its move into the next stage of the development of its primary technology, actually represents a step ahead of where it planned to be. The Company is developing its technology with the University of Central Florida in Orlando. In its first year, the plan was to develop a second-generation material that is designed to prevent post-surgical adhesions, complications from which can be devastating.
